NeoStem is focused on developing and building on its core capabilities in cell therapy, to capitalize on the burgeoning cell therapy industry as well as cell therapy’s future role in the fight against chronic disease; the company also desires to aid in lessening the economic burden these diseases pose. NeoStem’s mission is to become a premier cell therapy company. For more information, visit the company’s Web site at www.neostem.com.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research, sales, and trading services. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.

Let us hear your thoughts below: